Recap: Esperion Therapeutics Q4 Earnings

Esperion Therapeutics ESPR reported its Q4 earnings results on Tuesday, February 22, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Esperion Therapeutics beat estimated earnings by 22.03%, reporting an EPS of $-1.77 versus an estimate of $-2.27.

Revenue was up $5.76 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.17 which was followed by a 3.3% increase in the share price the next day.

Here's a look at Esperion Therapeutics's past performance:

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.